Trilafon Uses

Trilafon uses are primarily focused on treating adults who have schizophrenia or severe nausea and vomiting. As a "typical antipsychotic" medication, it works by lessening or blocking dopamine, a chemical in the brain, that can cause symptoms of schizophrenia or severe nausea and vomiting when elevated. Off-label Trilafon uses consist of treating agitation, dementia, and hiccups.

 

An Overview of Trilafon Uses

Trilafon® (perphenazine) is a prescription medicine known as a "typical antipsychotic" that has been licensed to treat schizophrenia and severe nausea and vomiting.
 

Trilafon Uses for Schizophrenia

Schizophrenia is one of the most confusing and disabling mental illnesses. The term refers to a group of mental disorders that involve abnormal thinking. Although the causes of schizophrenia are not fully understood, it is currently thought that genetics and environmental factors play important roles. Depending on the type of schizophrenia (see Types of Schizophrenia), symptoms may include the following:
 
  • Hallucinations
  • Delusions
  • Thought disorders
  • Disorders of movement
  • Flat affect (immobile facial expression, monotonous voice)
  • Lack of pleasure in everyday life
  • A diminished ability to initiate and sustain planned activity
  • Speaking infrequently, even when forced to interact
  • Poor executive functioning (the ability to absorb and interpret information and make decisions based on that information)
  • An inability to stay focused
  • Problems with working memory (the ability to keep recently learned information in mind and use it right away).
     
Although psychotherapy may be helpful for schizophrenia (see Psychosocial Therapy for Schizophrenics), medication is often essential for successful schizophrenia treatment. Trilafon can help improve the symptoms of schizophrenia.
 
(Trilafon Uses Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;